A previously healthy and active 72-year-old woman presents to your office with a complaint of stiffness and pain in her neck and shoulders. The symptoms are much worse in the morning and improve throughout the day. The pain affects the soft tissues and does not appear localized to the shoulder or hip joints. She denies headache or jaw claudication. Physical examination is unrevealing; there is no inflammatory synovitis, muscle tenderness, or skin rash. Muscle strength is normal in the deltoid and iliopsoas muscle groups. She has normal range of motion of the shoulder and hip joints. Laboratory studies reveal an elevated ESR of 92 mm/h and a mild normocytic anemia. Which of the following is the best next step in management of this patient?
A previously healthy and active 72-year-old woman presents to your office with a complaint of stiffness and pain in her neck and shoulders. The symptoms are much worse in the morning and improve throughout the day. The pain affects the soft tissues and does not appear localized to the shoulder or hip joints. She denies headache or jaw claudication. Physical examination is unrevealing; there is no inflammatory synovitis, muscle tenderness, or skin rash. Muscle strength is normal in the deltoid and iliopsoas muscle groups. She has normal range of motion of the shoulder and hip joints. Laboratory studies reveal an elevated ESR of 92 mm/h and a mild normocytic anemia. Which of the following is the best next step in management of this patient?
π‘ Explanation
## **Core Concept**
The patient's presentation suggests a systemic inflammatory condition given the elevated ESR, mild normocytic anemia, and symptoms of stiffness and pain that are worse in the morning and improve throughout the day. The absence of localized joint inflammation, muscle tenderness, or specific skin rash helps to narrow the differential diagnosis.
## **Why the Correct Answer is Right**
The clinical presentation of this patient, including morning stiffness, elevated ESR, and normocytic anemia without evidence of joint inflammation or muscle weakness, is highly suggestive of **Polymyalgia Rheumatica (PMR)**. PMR is a common inflammatory disorder that affects people over the age of 50, with a peak incidence in the 70s, and is more common in women. The condition characteristically presents with pain and stiffness in the neck, shoulders, and hips, which worsens in the morning. Laboratory findings often include an elevated ESR and sometimes a mild anemia. Given this diagnosis, the best next step in management would involve initiating treatment to alleviate symptoms and prevent potential complications.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include treatments not indicated for PMR or not addressing the likely diagnosis.
- **Option B:** Similarly, without specifics, one might guess this involves an incorrect approach, such as immediate imaging or invasive procedures not typically first-line for PMR.
- **Option C:** This could potentially involve a treatment not typically used as a first-line approach for PMR, such as biologic agents, which are not usually the initial treatment.
- **Option D:** Without specifics, assuming this is another incorrect approach, such as focusing solely on symptomatic relief without addressing the inflammatory component.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl in this case is that **Polymyalgia Rheumatica (PMR) is highly responsive to corticosteroids**. In fact, a dramatic response to a low dose of corticosteroids (e.g., prednisone 15-20 mg/day) is often considered a diagnostic criterion. The rapid improvement with corticosteroids can help confirm the diagnosis.
## **Correct Answer:** . **Glucocorticoids**.
β Correct Answer: A. Empiric trial of prednisone 15 mg daily
π€ Share this MCQ
Share Card Preview
π 1080x1080 square card β fills the full width in WhatsApp and Telegram